---
category: news
title: "Exscientia steps up AI-powered drug discovery with $60M Allcyte acquisition"
excerpt: "After closing a handful of deals this year worth more than $1.7 billion, Exscientia is ready to start spending that hard-earned cash. First on its shopping list? Allcyte, an Austrian company developing an AI platform to predict how well cancer treatments will work."
publishedDateTime: 2021-06-15T14:58:00Z
originalUrl: "https://www.fiercebiotech.com/medtech/exscientia-steps-up-ai-powered-drug-discovery-60m-acquisition-allcyte"
webUrl: "https://www.fiercebiotech.com/medtech/exscientia-steps-up-ai-powered-drug-discovery-60m-acquisition-allcyte"
type: article
quality: 37
heat: -1
published: false

provider:
  name: FierceBiotech
  domain: fiercebiotech.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://qtxasset.com/fiercebiotech/1623763706/artificial-intelligence-3382507_1920.jpg/artificial-intelligence-3382507_1920.jpg?pmWugZfoKMxJ0SB4z__2lINEQVMe3kF_"
    width: 1920
    height: 1280
    isCached: true

related:
  - title: "Exscientia buys Allcyte to add patient sample testing to its AI platform"
    excerpt: "UK-based artificial intelligence pioneer Exscientia has made a play to stay at the forefront of the field, acquiring Austrian rival Allcyte with the help of its recent $525 million financing"
    publishedDateTime: 2021-06-16T08:32:00Z
    webUrl: "https://pharmaphorum.com/news/exscientia-buys-allcyte-to-add-patient-sample-testing-to-its-ai-platform/"
    type: article
    provider:
      name: pharmaphorum.com
      domain: pharmaphorum.com
    quality: 38
    images:
      - url: "https://pharmaphorum.com/wp-content/uploads/2016/06/DNA-structure-generic-4.jpg"
        width: 1698
        height: 1131
        isCached: true
  - title: "Exscientia expands translational capabilities with Allcyte acquisition"
    excerpt: "Oxford, UK-based pharmatech company Exscientia has entered into a binding agreement to acquire artificial intelligence (AI) based precision medicine specialist Allcyte. Allcyteâ€™s technology platform uses AI to analyse drug activity in love patient samples at single-cell resolution."
    publishedDateTime: 2021-06-16T08:39:00Z
    webUrl: "https://www.pharmatimes.com/news/exscientia_expands_translational_capabilities_with_allcyte_acquisition_1371698"
    type: article
    provider:
      name: PharmaTimes
      domain: pharmatimes.com
    quality: 24
    images:
      - url: "https://www.pharmatimes.com/__data/assets/image/0007/1078171/deals.jpg"
        width: 620
        height: 460
        isCached: true
  - title: "Exscientia Acquires Personalised Medicine AI Pioneer Allcyte"
    excerpt: "Pioneering work by Allcyte has delivered a platform able to anticipate the effectiveness of cancer treatments in the clinic by using AI to analyse the activity of drugs in live patient samples at single-cell resolution."
    publishedDateTime: 2021-06-15T12:11:00Z
    webUrl: "https://www.tmcnet.com/usubmit/-exscientia-acquires-personalised-medicine-ai-pioneer-allcyte-/2021/06/15/9390381.htm"
    type: article
    provider:
      name: TMCnet
      domain: tmcnet.com
    quality: 19

secured: "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;sKVLQ/nqpOpFy6aF/woFlg=="
---

